Preliminary In Vitro Antiplatelet Potential of Ipomoea pes-caprae from North Lombok with Adenosine Diphosphate-Induced Platelet Aggregation

adenosine diphosphate antiplatelet Ipomoea pes-caprae phytochemical tannin

Authors

  • Ilsa Hunaifi
    ilsahunaifi@unram.ac.id
    Department of Neurology, Faculty of Medicine and Health Science, University of Mataram, Mataram, Indonesia
  • Dewi Suryani Department of Microbiology, Faculty of Medicine and Health Science, University of Mataram, Mataram, Indonesia
  • Lalu Husnul Hidayat Department of Pharmacy, Faculty of Medicine and Health Science, University of Mataram, Mataram, Indonesia
  • Muhammad Naufal Farras Ananta Department of Pharmacy, Faculty of Medicine and Health Science, University of Mataram, Mataram, Indonesia
  • Muhammad Iqbal Farobbi Department of Pharmacy, Faculty of Medicine and Health Science, University of Mataram, Mataram, Indonesia
  • Nisa Isneni Hanifa Department of Pharmacy, Faculty of Medicine and Health Science, University of Mataram, Mataram, Indonesia
  • Raisya Hasina Department of Pharmacy, Faculty of Medicine and Health Science, University of Mataram, Mataram, Indonesia
August 31, 2025

Downloads

Background: Cardiovascular diseases, particularly ischemic stroke, remain a global health burden, necessitating potential candidate for further antiplatelet with fewer side effects. Objectives: This study aimed to evaluate the antiplatelet potential of ethanolic extracts from the leaves and stems of Ipomoea pes-caprae (Katang-katang) from North Lombok, Indonesia, through ADP-induced platelet aggregation. Phytochemical screening, total tannin quantification, and in vitro antiplatelet assays were conducted. Methods: The leaves and stems were macerated with 96% ethanol, followed by qualitative phytochemical tests, Folin-Ciocalteu-based tannin analysis, and platelet aggregation inhibition assays using human platelet-rich plasma. Results: The extracts contained alkaloids, flavonoids, and tannins, with higher tannin levels in leaves (4.02 ± 0.02 mgEAT/g) than stems (3.67 ± 0.17 mgEAT/g). Concentration-dependent antiplatelet activity was observed, with leaf extracts showing inhibition (85.9% at 2000 μg/mL) compared to stems (79.5%) and aspirin (77.3%). IC₅₀ values were 727.78 μg/mL (leaves) and 349.95 μg/mL (stems). Statistical analysis confirmed significant differences across concentrations (p < 0.05). Conclusion: These findings demonstrate that Ipomoea pes-caprae exhibits potent antiplatelet activity, attributed to its tannin and phytochemical content, with leaves being more effective. Although these findings suggest preliminary antiplatelet potential, further analysis is required to validate the method using aspirin IC₅₀, and subsequent in vivo and pharmacological investigations are necessary before therapeutic application can be claimed.